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Abstract 
The photochemical behaviour of etodolac was investigated under various irradiation conditions. 
Kinetic data were obtained after irradiation of 10-4 M aqueous solutions by UVB, UVA and 
direct exposure to sunlight. The Xenon lamp irradiation was used in order to determine the 
photodegradation quantum yield under sun-simulated condition (ϕsun). The value was 
determined to be = 0.10 ± 0.01. In order to obtain photoproducts and for mechanistic purposes, 
experiments were carried out on more concentrated solutions by exposure to sunlight and to UVA 
and UVB lamps. The drug underwent photooxidative processes following an initial oxygen 
addition to the double bond of the five membered ring and was mainly converted into a spiro 
compound and a macrolactam. Ecotoxicity tests were performed on etodolac, its photostable 
spiro derivative and its sunlight irradiation mixture on two different aquatic trophic levels, plants 
(algae) and invertebrates (rotifers and crustaceans). Mutagenesis and genotoxicity were detected on 
bacterial strains. The results showed that only etodolac had long term effects on rotifers although at 
concentrations far from environmental detection values. A mutagenic and genotoxic potential was 
found for its derivative. 
 
Keywords: etodolac, photooxidation, indoles, acute and chronic toxicity, mutagenesis, 
genotoxicity. 
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1. Introduction 
Light and oxygen are two of the most important abiotic factors involved in the environmental fate 
of  xenobiotics, in aquatic systems and/or in the surface of soils. They received particular 
attention over the last decade (Brigante et al., 2005; Neilson and Allard, 2008; Lambropoulou 
and Nollet, 2014). Direct or photosensitized transformation in natural aquatic media can 
promote the complete degradation of the molecule, but in some cases leads to transformation 
products that can be more toxic and/or noxious than the parent compounds (Lambropoulou and 
Nollet, 2014; Sinclair and Boxall, 2003). 
Among the xenobiotics found in the environment, in the last years pharmaceuticals and personal 
care products (PPCPs) have been frequently detected worldwide (Fick et al., 2010; Negreira et al., 
2014). After their consumption, drugs are eliminated as parent compounds and/or metabolites 
through human excreta reaching sewage treatment plants (STPs). These plants are often not able to 
completely remove such xenobiotics which may escape removal processes and end in the aquatic 
compartment in the range of sub-ng/L – µg/L. Hence, phototransformation may be considered a 
more significant process compared to biodegradation in sunlit waters. Unpredictable effects 
can be also associated to the derivatives obtained by abiotic transformations and, on the basis of 
this evidence, the evaluation of the potential adverse effects of drugs and derivatives is of 
increasing scientific concern (Jjemba, 2006; Isidori et al., 2009). 
Among the most studied pharmaceuticals, the therapeutic group of nonsteroidal anti-inflammatory 
drugs (NSAIDs) is receiving great attention due to the worldwide use and frequent environmental 
occurrence. Many of these compounds have shown a significant photoreactivity, often 
associated to phototoxic side effects (Bosca et al. 2001). NSAIDs have not been detected in 
aquatic systems at concentrations able to cause acute toxic effects in non-target organisms; 
however, studies on chronic and genotoxic effects, as well as the fate of parent compounds and 
their derivatives, are still lacking. 
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We therefore focused our study on the drug etodolac (ETD), a member of the pyranocarboxylic 
acid group of NSAIDs. Approved by the U.S. Food and Drug Administration in 1991, it is used to 
treat mild to moderate pain, and to reduce inflammation associated to osteoarthritis and rheumatoid 
arthritis (Jones, 1999). In 2011 it was included in the list of high production volume 
pharmaceuticals that were not detected in the environment but were estimated to be 
persistent and/or bioaccumulated (Howard and Muir, 2011). However, in the same year the 
drug was detected in river waters at concentration of 0.3 ng/L (Hoshina et al., 2011). The drug 
is metabolized in the liver, and several metabolites, such as hydroxylated and glucuronide 
derivatives, have been identified in human plasma and urine (Strickmann and Blaschke, 2001). 
Products deriving from decarboxylation and ring opening have been found in aqueous 
solutions at high temperature (75-95 °C) at different pH values (Lee et al., 1988). To our 
knowledge, data on the photoreactivity of etodolac have not been reported in literature. The drug 
ETD (Figure 1) contains, in its structure, the indole system that is a chromophore present in 
many molecules of biological interest, in such drugs as indomethacin (Wu et al.1997; Temussi 
et al, 2011), fluvastatin (Cermola et al. 2007), and vinblastine sulfate (Black et al. 1988) which 
show photoreactivity. This study aimed to evaluate the photochemical behaviour of etodolac 
under photochemical conditions with particular attention to identify the main photoproducts 
and elucidate the photolysis reaction pathway. Parent compound and derivatives were tested for 
their aquatic toxicity in algae, rotifers and crustaceans. The unicellular green alga 
Pseudikirchneriella subcapitata, the freshwater rotifer Brachionus calyciflorus and  the 
microcrustacean Ceriodaphnia dubia (Cladocera, Crustacea) were selected as representative aquatic 
organisms since they have a widespread geographic distribution and a strong impact on several 
important ecological processes in waters. The mutagenesis and genotoxicity were evaluated with 
and without metabolic activation (S9) through the salmonella mutagenicity assay in TA98 and 
TA100 Salmonella typhimurium strains and the UMU test in the Salmonella typhimurium 
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TA1535/pSK1002 to detect point mutations and to induce the umuC-gene in response to genotoxic 
lesions in the DNA, respectively.  
 
2. Materials and Methods 
2.1 Chemicals 
Etodolac (ETD, 1), (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-β]indole-1-acetic acid) was 
supplied by Kemprotec. It was at least 98% pure. All chemicals were used without further 
purification unless otherwise indicated. Solvents were of HPLC grade and they were supplied by 
Sigma- Aldrich. Water was of  Milli-Q quality and was obtained from a Milli-Q gradient system 
(Millipore).  
For toxicity and genotoxicity tests the photoproducts (see section 2.5) were dissolved in 
dimethylsulfoxide (Sigma-Aldrich Chemicals) because of their low solubility in water, sonicated at 
40 kHz for 20 min at room temperature by using an ultrasonic bath (Sonica®, SOLTEC, 
Milan, Italy), and further diluted in double-deionized water to obtain stock solutions. The test 
solutions were prepared by mixing the appropriate volumes of the stock solutions and the test 
media. In the test solutions, DMSO percentage was lower than 0.02% v/v. For each test a 
solvent control was performed. 
2.2 Analytical instruments 
Nuclear magnetic resonance (NMR) spectra were recorded on a Varian Inova-500 instrument 
operating at 499.6 and 125.6 MHz for 1H and 13C, respectively, and referenced with deuterated 
solvents (CDCl3 or CD3OD). The carbon multiplicity was evidenced by distortion-less enhancement 
by polarisation transfer (DEPT) experiments. The proton couplings were evidenced by 1H-1H 
COSY experiments. The heteronuclear chemical shift correlations were determined by HMQC and 
HMBC pulse sequences.  
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IR spectra were recorded on a Jasco FT/IR-430 instrument equipped with single reflection ATR 
using CHCl3 as solvent.  
UV–Vis spectra were recorded with a Varian Cary 300 UV–Vis spectrophotometer or on a 
PerkinElmer Lambda 7 spectrophotometer.  
pH was measured with a Metrohm combined glass electrode, connected to a Metrohm 713 pH-
meter.  
HPLC-UV was an Agilent 1100 Series binary pump HPLC equipped with a UV detector set at 254 
nm. The column used was a Gemini C18 (5µm, 250 mm x 4.6 mm, Phenomenex) with a flow rate 
of 0.4 mL min-1. The mobile phase was: water with 0.1% formic acid (A) and acetonitrile (B). The 
gradient elution was: at initial time B 30 % and A 70%, followed by a linear gradient to B 75 % 
within 55 min, the ratio was maintained constant for 5 min, then the ratio returned to B 30% in 5 
min. 
LC-HR-MS analysis was carried out on an LC-MS system (Agilent 1100 Series, binary pump) 
equipped with an ion trap mass selective detector (MSD VL) and a UV diode array detector. 
The adopted column was a Sphere Clone C18 (4.6 µm, 250 mm x 5 mm, Phenomenex) and the 
gradient elution was 5% acetonitrile and 95% water followed by a linear gradient to 95% 
acetonitrile within 30 min, keeping constant the latter conditions for a further 15 min. The 
flow rate was 0.4 mL min-1. 
Analytical and preparative TLCs were made on Kieselgel 60 F254 plates with 0.2 mm, 0.5 or 1 mm 
layer thickness, respectively (Merck). 
2.3 Irradiation set-up 
All irradiation experiments were performed in H2O-CH3CN (9:1 v/v) mixture (to have clear 
solution), except when specified, and were performed in triplicate. Solutions at 1 mM 
concentration were used to isolate photoproducts, whereas concentrations between 0.1-0.5 
mM were choose for kinetic analyses.  
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Three different kinds of lamps (UVA, UVB and Xenon lamp) and two irradiation set-up (system I 
and system II) were used in order to investigate the degradation of etodolac (100-500 µM) and 
separate the photoproducts for the spectroscopic characterization and ecotoxicological tests (1 
mM).  
System I: a thermostated cylindrical reactor of 40 mL, cooled by water circulation at a temperature 
of 15  2°C in order to limit thermal reactions, was located at one focal point of the a Xenon lamp 
(solar simulator) in order to maintain a constant irradiation of the whole sample and was equipped 
on the top with a pyrex filter removing the wavelengths lower than 285 nm. Samples were 
continuously stirred with a magnetic stirrer to ensure homogeneity. Emission spectrum of lamp 
was measured with an Ocean Optics SD 2000 CCD spectrophotometer (calibrated using a 
DH-2000-CAL Deuterium Tungsten Halogen reference lamp). The incident photon flux in the 
UV region (285-400 nm) was quantified to be 34.4 W m-2. The Xenon lamp irradiation 
experiment was performed in order to estimate the degradation rate of ETD and 
polychromatic degradation quantum yield under sun-simulated conditions. 
For the UVB and UVA irradiation (system II) a photoreactor (Multirays, Helios Italquartz) 
equipped with six 15W lamps with a maximum at 313 nm (UVB) or with four 15W  lamps with a 
maximum at 366 nm (UVA) was used. 
Finally, a solution of ETD was exposed to sunlight in H2O-CH3CN (9:1 v/v) (0.5 mM) in a 
closed quartz tube and samples were withdrawn in order to follow the ETD disappearance 
and the formation of main photoproducts under naturally sun irradiation conditions.  
2.4  Kinetics constant and quantum yield determination 
The time evolution of etodolac was fitted with a pseudo-first order equation C0 = Ct e
-kt where C0 
was the initial drug concentration, Ct the concentration at time t and k the pseudo-first order 
degradation rate constant. Assuming the drug as the only absorbing species present in water, the 
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polychromatic quantum yield degradation (Φ) was calculated in the overlap range of etodolac 
absorption spectrum with lamp emission spectrum, as follows: 
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where I0 is the incident photon flux, ε is the molar absorption coefficient of xenobiotic, d the optical 
path length inside the cells and [X] the initial etodolac concentration. λ1 and λ2 represent the 
interval of integration, that is the overlap range between etodolac absorption and lamp 
emission spectrum (λ1 = 285 nm and λ2 = 310 nm). 
Photoproducts were isolated and purified and the calibration curve was performed in HPLC-
UV in order to follow their formation during ETD disappearance.  
2.5 Photoproducts isolation 
In order to isolate and characterize the main photoproducts, two solutions of etodolac at 1 
mM were irradiated.  The first one (50 mg of ETD) was exposed to sunlight (October 2013, 
Naples) for 3 days. After evaporation of the solvents, the mixture was separated by 
preparative TLC. Elution with Et2O gave compound 2 (7 mg), etodolac (1 mg), compound 3 
(11 mg) and an intractable material (12 mg). 
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The second solution (50 mg) was irradiated by UVB lamps for 1 h, then irradiation mixture 
was handled as reported before. The chromatographic separation gave compound 2 (30 mg), 
etodolac (8 mg) and an intractable material (8 mg). ETD and compounds 2 and 3 were fully 
characterized and all data are reported in Table 1. 
2.6 Ecotoxicity tests 
Aquatic toxicity was performed on pure etodolac (1), its isolated photostable spiroderivative 2 
and its crude sunlight irradiation mixture (obtained after three days exposure). Each dried test 
sample was firstly dissolved in DMSO and further diluted in double-deionized water. The 
toxicity was determined on Pseudokirchneriella subcapitata, Brachionus calyciflorus and 
Ceriodaphnia dubia. 
  2.6.1 Acute toxicity 
 The B. calyciflorus (ASTM E1440-9, 2004) test was performed on organisms less than 2 h old that 
hatched from cysts supplied by MicroBioTest Inc. (Nazareth, Belgium). The organisms were 
hatched 16–18 h before the beginning of the test, in synthetic freshwater (moderately hard medium), 
at 25 ± 1 °C and under continuous illumination (3000–4000 lux). Tests were performed in multiwell 
plates, 0.3 mL of test solution (five concentrations following a geometric progression of  2) was 
tested in six replicates with five organisms per well.  
The C. dubia test was performed over 24 h of exposure using young organisms less than 24 h old 
and following EPA-600-4-90 (applied to reference toxicant) procedures (US EPA, 1993). 
Organisms were hatched from ephippia (MicroBioTest) after 3–4 d of incubation under a light 
source of 6000 lux at 25 ± 1 °C in synthetic ISO medium. Tests were performed in 24-well plates 
with 10 crustaceans per well (1.0 mL of test solution), five concentrations and three replicates per 
concentration.  
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For each test, plates were incubated in darkness at 25 ± 1 °C for 24 h. Mortality was the test 
parameter and the concentration that induced the 50% effect compared to negative control was 
indicated as median lethal concentrations, LC50.  
 2.6.2 Chronic toxicity 
The test on P. subcapitata was performed in 96-well microplates according to Paixao et al.  (2008). 
The algal cells were collected from an exponentially growing pre-culture according to ISO 8692 
(2004). The compounds (five concentrations, geometric progression 2) and the negative control 
were incubated with 104 cells/mL of algal suspension in six replicates; the final test volume was of 
0.3 mL per well. The plates were incubated under continuous illumination (light source 6000 lux) at 
25 ± 1 °C on a microplate shaker (450 rpm). The plates were read at 450 nm (Spectra fluor, Tecan, 
Switzerland) immediately before the test and every 24 h for 72 h. 
The chronic toxicity test on B. calyciflorus was performed according to ISO 20666 procedure (ISO, 
2008). Organisms, less than 2 h old, were hatched in the same conditions of acute assay. The tests 
were performed in multiwell plates, 0.9 mL of test solutions (five concentrations, geometric 
progression 3) were tested in six replicates with one rotifer per well. Organisms were fed with 0.1 
mL of P. subcapitata fresh suspension (107 cells/mL). Plates were incubated in the dark at 25 ± 1 °C 
for 48 h.  
The population growth inhibition was the test parameter considered for both chronic assays and the 
concentrations that gave the 50% effect compared to negative control were indicated as median 
effective concentrations, EC50. 
 2.6.3 Mutagenesis/genotoxicity tests  
The salmonella mutagenicity assay was performed without metabolic activation (S9) on TA98 and 
TA100 Salmonella typhimurium strains. The TA98 strain was utilized to evaluate frame-shift 
mutations, while the TA100 was used to assess base-pair substitutions. Five compound 
concentrations (0.1 mL) and 0.1 mL of medium containing 108 cells were incorporated into agar 
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plate with 0.5 mL phosphate buffer to evaluate the direct mutagenicity. Three plates for each 
concentration were incubated at 37 °C for 72 h in the dark and then the number of His+ revertants 
was counted. Sodium azide (5, 10 and 20 µg/mL)  for TA100 and 2-nitrofluoren (2.5, 5 and 10 
µg/mL) for TA98 were used as positive controls. The test parameter considered was Mutagenic 
Ratio (MR) calculated as the ratio between the mean number of revertants/plate of compound and 
the spontaneous revertants of the negative control. A compound was considered mutagenic when 
the MR was >2 with a clear dose–response relationship (EPA-600/4-82-068, 1983).  
Genotoxicity was assessed by the umu-test according to the ISO 13829 procedure (ISO, 2000). The 
umu-test is a colorimetric assay based on the ability of genotoxic agents to induce the umuC-gene 
expression in the Salmonella typhimurium TA1535/pSK1002 strain in response to genotoxic lesions 
in the DNA. The umuC-gene expression can be easily monitored by β-galactosidase activity since 
the test strain contains the umuC-gene fused with the lacZ-gene. The assay was performed in 96-
well microplates with and without S9 mix (0.45 mL of S9 fraction was added to 15 mL of bacterial 
suspension) to detect indirect and direct genotoxic effects.  Five  concentrations were tested in six 
replicates; 4-nitroquinoline N-oxide (0.05 µg/mL) and 2-aminoanthracene (2 µg/mL) were used as 
positive controls for direct and indirect genotoxicity, respectively. The production of β-
galactosidase was assessed measuring the absorbance at 420 nm (Spectrafluor; Tecan, Mannedorf, 
Switzerland). Bacterial growth was measured at 600 nm and the Growth factor (G) was determined 
as (A600,T – A600,B)/(A600,N – A600,B ) where A600,T = absorbance of the sample well at 600 nm; A600,N 
= absorbance of the negative control at 600 nm and A600,B = absorbance of the blank at 600 nm. The 
test parameter considered was Induction Ratio (IR)=1/G∙[(A420,T – A420,B)/(A420,N – A420,B)] where 
A420,T = absorbance of the sample well at 420 nm; A420,B = absorbance of the blank at 420 nm; 
A420,N = absorbance of the negative control at 420 nm. A compound was considered genotoxic when 
IR value was > 1.5 with an evident dose–response effect.  
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3. Results and Discussion 
UV-vis spectrum of etodolac (ETD) at pH 2.0, 7.0 and 10.0 is reported in Figure 1 showing that 
any significant variation could be appreciated over a large range of pH values. Etodolac 
spectra show two absorption bands centred at λ 225 nm and 272 nm with molar absorption 
coefficients of 42600 and 8290 M-1 cm-1, respectively.  
Preliminary experiments to test the stability of the drug in the dark were performed at room 
temperature at various environmentally relevant pH (from 4.0 up to 9.0) (Valenti et al., 2009) 
showing that any significant transformation can be appreciated after 24 hours. 
From preparative irradiations of ETD under UVB and sunlight two main photoproducts were 
isolated, characterized by NMR, mass and structures are reported in Table 1. For the 
photoproduct 2 LC-HR-MS analysis presents a molecular peak at 304.1471 m/z [M+H]+ 
(with M corresponding to Mdrug + O), the peaks at 286.1611 m/z [M-OH]+ and m/z 244.1440 
[M-CH2COOH]+. 13C-NMR analysis shows the presence of a signal at δ 181.2 due to the 
ketone function (C-3) and a signal at δ 60.8 assigned to the spiro carbon (C-2). HMBC 
spectrum evidences correlations of H-4’ methylene protons with C-1’, C-3’ and carbonyl 
carbon (C-3). The methylene protons of the acetic acid side chain (C-5’), in the HMBC 
experiment, give heterocorrelations with the C-1’ quaternary carbon, the carboxylic carbon 
(C-6’), and C-2 spiro carbon.  
For the photoproduct 3, the LC-HR-MS analysis shows a molecular peak at 320.2069 m/z 
[M+H]+ (with M corresponding to Mdrug + 2 O) and fragmentation peaks at 302.2107 m/z [M-
OH]+ and 260.2204 m/z [M-CH2COOH]+. 13C-NMR analysis shows the presence at 
downfield of a carbonyl carbon at  204.6 (C-3) and an amidic carbon at  172.0 (C-2). 
HMBC spectrum evidences correlations of the carbonyl carbon (C-3) with protons at  
4.45 and 4.16 assigned to the oxymethylene group (C-3’). The methylene protons of the 
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acetic acid function (C-5’), in the HMBC experiment, give heterocorrelation with the 
quaternary carbon at  80.7 (C-1’) and the carboxylic carbon at  177.5 (C-6’). 
As reported in Figure 2, the effect of UV radiation was investigated on the ETD degradation 
and generation of photoproducts 2 and 3. Under UVB the main photoproduct is compound 2. 
After 30 min of irradiation about 70 % of ETD (corresponding to 300 µM) is degraded into 
spiro compound 2 (200 µM), while lactam 3 formation occurs only at smaller amount (~30 
µM). 
Under UVA irradiation 65% degradation of ETD occurs after 360 min (about 370 µM) and 
concentrations of spiro 2 and lactam 3 are about 150 and 180 µM, respectively. 
Finally, a drug solution was exposed to sunlight and it was observed a half-life time of about 
one day (~11 hours of light). The degradation kinetics for sun radiation were calculated 
considering that the daylight in October (Naples, Italy) is in average of 11 hours for day. As 
shown in Figure 2, during the first hours of irradiation the photoproduct 3 is rapidly formed, 
after one day its concentration slowly decreases until complete degradation. A different 
behaviour is observed for photoproduct 2: its initial formation rate is slower than that of 
product 3, but it is photostable and after the complete etodolac degradation its concentration 
(~250 µM) remains almost unchanged for two weeks. Initial degradation rate of ETD (
d
ETDR , 
M s-1) has been quantified to be 2.74 ± 0.12 × 10-7 M s-1 and 3.40 ± 0.06 × 10-8 M s-1 under UVB 
and UVA, respectively. Using Xenon lamp irradiation the 
d
ETDR , M s
-1 was 1.06 ± 0.03 × 10-8 
M s-1 giving a polychromatic quantum yield ϕ in the UV-region of 0.10 ± 0.01. Interestingly, 
the degradation rate was close to those estimated using natural sun radiation (6.18 ± 0.19 × 10-
8 M s-1). 
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As reported in Figure 3, after ~90 min etodolac (25% of degradation) is converted to 
photoproduct 3 for 20% and compound 2 for 5% . These ratios are inverted when the drug is 
completely degraded, in this case a formation of 40% for 3 and 47% of 2 is observed. 
All these results highlight the strong dependence of photoproduct distribution on irradiation 
wavelengths. For example, after 50% of degradation, etodolac is converted in compound 2 for 
17% (UVA), 11% (sun), 42% (UVB), and in compound 3 for 33% (UVA), 39% (sun), 8% 
(UVB) (Figure 3). The most important differences are observed between UVA and UVB, the 
photoproduct distribution for sunlight exposure is more similar to UVA than UVB 
distribution due to the high contribute of UVA light to sun spectrum. 
3.1 Mechanistic hypothesis 
Photoproducts 2 and 3 are oxygenated compounds and this highlights the oxygen involvement 
in the etodolac transformation. These compounds are not produced under de-areated 
conditions. Indeed, experiments showed that when the drug (1 mM) was irradiated with UVA 
or UVB lamps under argon atmosphere, it was recovered almost unchanged even after one 
hour. Irradiation in aerated acetonitrile was equally slow but the formation of compounds 2 
and 3 were observed showing that water is not determinant in their formation. 
Rearrangement reactions to form spiro compounds from indoles have been sometime 
observed in photooxygenation reactions of indoles (Iesce et al., 2005) and in some cases 
the related intermediates have also been evidenced (Mateo et al., 1996). Moreover, this 
kind of products (spiro compounds) are found mainly in the photooxygenation of indoles 
where the pyrrolic ring is condensed with hexatomic hetero- (Mateo et al., 1996) or 
carbocycle (Cermola et al., 2007), like in etodolac. Analogously, formation of products 
with oxidative heterocyclic ring breakage, as photoproduct 3, has been reported 
(Cermola et al., 2007; Temussi et al., 2011). According to literature and to our data, a 
plausible phototransformation pathway is depicted in Scheme 1. The excited drug should 
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undergo oxygen attack to C2-C3 bond leading, via diradical 4, to hydroperoxide 5; the 
latter should give the corresponding alcohol 6 via homolysis followed by H abstraction 
from the solvent (Dussault, 1995) or, mainly, via water involvement (Mateo et al., 1996). 
As proved by Mateo et al. (1996), alcohol 6 in the presence of a weak acid (all species 
have a carboxylic acid group) should rearrange to photoproduct 2. Both diradical 4 and 
hydroperoxide 5 could lead to dioxetane 7, that through the well -known C-C and O-O 
bonds cleavage should give lactam 3 (Iesce et al., 2005).  
The proposed reaction pathway is supported by literature data and also by LC-MS analysis of 
the irradiation mixture (after 10 min UV-B irradiation, 0.5 mM). The LC-HR-MS data 
evidenced the presence of 1, 2 and two intermediate compounds with [M+H]+ peaks at 
320.1463 and 304.1704 m/z that could be attributable to intermediates 5 and 6, respectively. 
They are unstable in our conditions and rapidly disappeared with increasing of the peak of 
spiro 2. Both compounds 5 and 6 were not recovered by chromatography due to instability 
and very low amounts. 
Lactam 3 was found by sunlight exposure or UVA lamps. This should be due to these 
mild irradiation conditions that are favorable for UV-sensitive peroxidic and 
hydroperoxidic species (Iesce et al., 2005) and to the photosensitivity of lactam 3. In fact, 
irradiation experiments of photoproducts showed that lactam 3 (1 mM) was completely 
degraded within three hours by UVB light and in 15 days by sunlight exposure. Under 
the latter conditions spiro 2 remained unchanged over time up to 2 weeks.  
 3.2 Ecotoxicological results 
Etodolac, its photostable derivative 2 and its sunlight irradiation mixture, obtained simulating 
the environmental photodegradation, were subjected to acute and chronic toxicity tests on 
organisms from two trophic aquatic levels. Solvent controls showed no toxicity at the 
concentrations tested. The results of acute toxicity tests, expressed as median lethal 
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concentrations (LC50) and chronic toxicity tests, expressed as median effective 
concentrations (EC50) are reported in Table 2. The range of concentrations tested for acute 
and chronic toxicity was in the order of mg/L, certainly higher than the etodolac 
environmental concentrations detected in the order of ng/L (Hoshina et al., 2011). As shown 
in Table 2, parent compound and its derivative were neither acutely toxic in rotifers and 
crustaceans up to 25 mg/L nor in the long-term exposure in  algae up to 10 mg/L. Only 
etodolac induced a chronic effect expressed as 50% reproduction inhibition in B. calyciflorus 
at 15.44 mg/L. At the best of our knowledge, no ecotoxicity data exists for this drug nor for 
its derivative. Some studies, performed on the most detected NSAIDs in aquatic systems, 
demonstrated the low acute toxicity of such compounds in non-target organisms, with much 
higher short-term EC50 values than their environmental occurrence (Cleuvers, 2004; Parolini 
et al., 2012). Kawabata et al. (2013) studied sulindac and indomethacin, two NSAIDs of the 
indole acid class as etodolac, showing ecotoxicity values in bacteria in the same order of 
magnitude found for etodolac.  
Although in the present study the phototrasformation process did not produce a toxic 
derivative, the sunlight-exposed samples show often differences in toxicity when compared to 
parent compound with formation of more or less hazardous derivatives  for the environment 
and human health. Indeed, Schmitt-Jansen et al. (2007) evaluated the phytotoxicity of 
diclofenac, a NSAID belonging to the family of carboxylic acid derivatives, after exposure to 
natural sunlight. These authors demonstrated that the increasing concentration of 
transformation products significantly correlated with enhanced phytotoxicity. On the contrary 
Kawabata et al. (2013) reported that the photoproducts of sulindac and indomethacin were 
less toxic in bacteria than parent compounds. In the present research, the photo -exposed 
solution was also examined to detect possible additive, synergistic or antagonistic toxic 
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effects of the mixture photodegradation products and neither acute nor chronic toxicity was 
found.  
In order to better determine the real environmental impact of etodolac, in our study  we have 
also investigated the mutagenic and genotoxic properties of the parent compound, its 
photostable derivative 2 and the sunlight irradiation mixture. The mutagenesis results are 
shown in Table 3, where Mutagenic Ratios (MR) higher than 2 and a clear dose-related effect 
in TA98 strain was found for the photostable derivative and the mixture in the range of 6.25–
25 and 12.5-25  μg/mL, respectively, suggesting that they are direct frame-shift mutagens. 
The photostable derivative was shown to be also a base-pair substitution mutagen in TA100, 
in the range of 6.25-25 μg/mL. Our results showed that the parent compound 
photodegradation leads to the formation of a derivative with mutagenic properties even if in 
the sunlight irradiation mixture the presence of other not identified photodegradation products 
reduced the activity of the photostable derivative (2) probably for antagonistic effects.  
UMU-test results are shown in Table 4. Etodolac and sunlight irradiation mixture did not 
induce DNA damage with and without S9 mix, while the photostable derivative was found a 
direct genotoxic agent with an Induction Ratio (IR) higher than 1.5 star ting from 3.125 mg/L. 
In the UMU-test, the photoproduct showed higher activity than parent compound as it 
has been shown in the Salmonella mutagenicity assay. Furthermore, the mixture 
exhibited lower activity than photoproduct according to the Salmonella assay results 
probably due to an antagonistic effect exerted by other not identif ied photodegradation 
products. The genotoxic properties of the derivative were totally suppressed by microsomal 
metabolic system.  
Nowadays no data about mutagenicity and genotoxicity of etodolac as well as of 
photoproducts exists. However, the low activity of parent compound was confirmed by 
previous studies performed on different NSAIDs in which such compounds did not induce 
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gene mutations in Salmonella typhimurium strains and were not able to produce DNA damage 
at environmental concentrations (Philipose et al., 1997;  Giri and Mukhopadhyay, 1998; 
Isidori et al., 2005; Parolini et al. 2011).  
 
4. Conclusion 
Photochemical fate of etodolac was investigated under polychromatic wavelength (UVB, UVA 
and sun-simulated conditions). Moreover the half-life was estimated to be of about 1 day 
under solar exposition. Two major photoproducts have been isolated and characterized by NMR 
and HPLC-MS tools. Under UVA, both spiro compound (2) and a macrocyclic lactam (3) are 
generated while under UVB radiation mainly the compound spiro, found to be genotoxic, was 
observed. Moreover the spiro compound results to be photostable under sunlight exposure after 
up to 2 weeks suggesting the possible accumulation in aquatic media. 
The work gives further information on the reactivity of indoles, a system widely present in natural 
bioactive molecules as well as in several synthetic drugs. In particular, it confirms the easy 
photoreactivity of heterocyclic pyrrole ring under oxidative conditions and the tendency of this 
heterocycle, especially when condensed to an aromatic ring, as in indoles, to generate radical 
oxygenated species. Photochemical studies of xenobiotics, in particular drugs, in addition to the 
environmental interest, aim at obtaining information on the photochemical reactivity of certain 
features present in these molecules (structure-photoreactivity relationship). Given the complexity 
and heterogeneity of drugs, it is difficult to predict or rationalize their behavior in the environment. 
On the other hand, the knowledge of factors (substituents, solvents) that affect the photochemical 
behavior of organic molecules are limited to relatively simple derivatives.  
Our toxicological data evidenced that etodolac and its photostable derivative are not of particular 
environmental concern as long as their toxicity occurs at very high concentrations, far above the 
detected environmental occurrence. Such results are consistent with the toxicity levels found 
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for other NSAIDs. Nevertheless, the derivative exhibited mutagenic and genotoxic activity 
highlighting the need of investigating other relevant potential effects that to date are not clearly 
regulated by the environmental risk assessment guidelines. 
 
 
References 
ASTM E 1440-91. Standard guide for acute toxicity with the rotifer Brachionus. American Society 
for Testing and Materials. Philadelphia PA, USA, reapproved; 2004. 
Black J, Buechter DD, Chinn JW, Gard J, Thurston DE. Studies on the stability of vinblastine 
sulfate in aqueous solution. J Pharm Sci 1988;77:630-4. 
Bosca F, Marin ML, Miranda MA. Photoreactivity of the nonsteroidal anti-inflammatory 2-
arylpropionic acids with photosensitizing side effects. Photochem Photobiol 2001;74: 637-
55. 
Brigante M, DellaGreca M, Previtera L, Rubino M, Temussi F. Degradation of 
hydrochlorothiazide in water. Environ Chem Lett 2005;2: 195-8. 
Cermola F, DellaGreca M, Iesce MR, Montanaro S, Previtera L, Temussi F, Brigante M. Irradiation 
of fluvastatin in water. Structure elucidation of photoproducts. J Photochem Photobiol A: Chem 
2007;189:264-71.  
Cleuvers  M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen and 
acetylsalicylic acid. Ecotox Environ Safe 2004;59:309-15. 
Dussault P. Reactions of hydroperoxides and peroxides. In: Foote CS, Valentine JS, Greenberg A, 
Liebman JF, editors. Active Oxygen in Chemistry. London: Chapman & Hall; 1995. p. 141-
203. 
EPA-600/4-82-068. Interim procedures for conducting the Salmonella/microsomal mutagenicity 
assay (Ames test), Las Vegas, USA, 1983. 
Fick J, Lindberg RH, Tysklind M, Larsson DGJ. Predicted critical environmental concentrations for 
500 pharmaceuticals. Regul Toxicol Pharm 2010;58:516-23. 
Giri AK, Mukhopadhyay A. Mutagenicity assay in Salmonella and in vivo sister chromatid 
exchange in bone marrow cells of mice for four pyrazolone derivatives. Mutat Res 1998; 
420(1-3):15-25. 
 20 
 
Hoshina K, Horiyama S, Matsunaga H, Haginaka J. Simultaneous determination of non-steroidal 
anti-inflammatory drugs in river water samples by liquid chromatography–tandem mass 
spectrometry using molecularly imprinted polymers as a pretreatment column. J Pharm Biomed 
Anal 2011;55:916-22.  
Howard PH, Muir DCG. Identifying new persistent and bioaccumulative organics among 
chemicals in commerce II: pharmaceuticals. Environ Sci Technol 2011;45:6938-46. 
Iesce MR, Cermola F, Temussi F. Photooxygenation of Heterocycles. Curr Org Chem 2005;9:109-
39. 
Isidori M, Lavorgna M, Nardelli A, Parrella A, Previtera L, Rubino M. Ecotoxicity of naproxen and 
its phototransformation products. Sci Total Environ 2005;348: 93-101. 
Isidori M, Parrella A, Pistillo P, Temussi F. Effects of ranitidine and its photoderivatives in the 
aquatic environment.  Environ Int 2009;35:821-5. 
ISO 8692. Water quality -fresh water algal growth inhibition test with Scenedesmus subspicatus and 
Selenastrum capricornutum. Geneva Switzerland: International Organization for 
Standardization; 2004. 
ISO 13829. Water quality -determination of the genotoxicity of water and waste water using the 
umu-test. Geneva Switzerland: International Organization for Standardization; 2000. 
ISO 20666. Water quality-determination of chronic toxicity to Brachionus calyciflorus in 48 h-
population growth inhibition test. Geneva Switzerland: International Organization for 
Standardization; 2008. 
Jjemba PK. Excretion and ecotoxicity of pharmaceutical and personal care products in the 
environment. Ecotox Environ Safe 2006;63:113-30. 
Jones RA. Etodolac: an overview of a selective COX-2 inhibitor. Inflammopharmacol 1999;7:269-
75. 
Kawabata K, Sugihara K, Sanoh S, Kitamura S, Ohta S. Photodegradation of pharmaceuticals in the 
aquatic environment by sunlight and UV-A, -B and –C irradiation. J Toxicol Sci 2013; 38:215-
23. 
Lambropoulou DA, Nollet LML. Transformation products of emerging contaminants in the 
environment. Wiley & Sons Ltd: United Kingdom; 2014. 
Lee YJ, Padula J, Lee HK. Kinetics and mechanisms of etodolac degradation in aqueous solutions. J 
Pharm Sci 1988;77:81-6. 
 21 
 
Mateo CA, Urrutia A, Rodrıguez JG, Fonseca I, Cano FH. Photooxygenation of 1,2,3,4- 
tetrahydrocarbazole: synthesis of spiro[cyclopentane-1,2’-indolin-3’-one]. J Org Chem 
1996;61:810-2. 
Negreira N, López de Alda M, Barceló D. Cytostatic drugs and metabolites in municipal and 
hospital wastewaters in Spain: Filtration, occurrence, and environmental risk. Sci Total Environ 
2014;497-498:68-77. 
Neilson AH, Allard AS. Environmental degradation and transformation of organic chemicals. 2nd 
ed. CRC Press: Boca Raton, Fl, USA; 2008. 
Paixao SM, Silva L, Fernandes A, O'Rourke K, Mendonca E, Picado A. Performance of a 
miniaturized algal bioassay in phytotoxicity screening. Ecotoxicology 2008;17:165-71. 
Parolini M, Binelli A, Provini A. Assessment of the potential cyto–genotoxicity of the Nonsteroidal 
Anti-Inflammatory Drug (NSAID) diclofenac on the zebra mussel (Dreissena polymorpha). 
Water Air Soil Poll 2011;217:589-601. 
Parolini M, Binelli A. Sub-lethal effects induced by a mixture of three non-steroidal anti-
inflammatory drugs (NSAIDs) on the freshwater bivalve Dreissena polymorpha. Ecotoxicology 
2012;21:379-92. 
Philipose B, Singh R, Khan KA, Giri AK. Comparative mutagenic and genotoxic effects of three 
propionic acid derivatives ibuprofen, ketoprofen and naproxen. Mutat Res 1997;393(1-2):123-
31. 
Schmitt-Jansen M, Bartels P, Adler N, Altenburger R. Phytotoxicity assessment of diclofenac and 
its phototransformation products. Anal Bioanal Chem 2007;387:1389-96. 
Sinclair CJ, Boxall AB. Assessing the ecotoxicity of pesticide transformation products. Environ Sci 
Technol 2003;37:4617-25. 
Strickmann DB, Blaschke G. Isolation of an unknown metabolite of the non-steroidal anti-
inflammatory drug etodolac and its identification as 5-hydroxy etodolac. J Pharm Biomed Anal 
2001;25:977-84. 
Temussi F, Cermola F, DellaGreca M, Iesce MR, Passananti P, Previtera L, Zarrelli A. 
Determination of photostability and photodegradation products of indomethacin in aqueous 
media. J Pharm Biomed Anal 2011; 56:678-83. 
US EPA, 1993. Methods for measuring the acute toxicity of effluents and receiving waters to 
freshwater and marine organisms, fourth ed. EPA-600-4-90. Washington DC: US 
Environmental Protection Agency. 
 22 
 
Valenti TW, Perez-Hurtado P, Chambliss CK, Brooks BW. Aquatic toxicity of sertraline to 
Pimephales promelas at environmentally relevant surface water pH. Environ Toxicol Chem 
2009;28:2685-94. 
Wu AB, Cheng HW, Hu CM, Chen FA, Chou TC, Chen CY.  Photolysis of indomethacin in 
methanol. Tetrahedron Lett 1997;38:621-2.  
 
1Fig. 1
1Fig. 2
Figure 3
Figure Caption
Fig. 1. UV-vis spectra of etodolac (ETD) at different pH values in H2O/CH3CN mixture 9:1
(v/v). Insert chemical structure of etodolac.
Fig. 2. Degradation profiles of ETD and formation of photoproducts 2 and 3 as a function of
different irradiation times under UVB, UVA and sun (autumn in Italy) irradiation.
Fig. 3. Ratio of photoproducts 2 and 3 generation (z-label) as a function of ETD degradation
(y-label) under UVB, UVA and sun irradiation (x-label).
Scheme 1. Suggested pathways for photoproducts 2 and 3.
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Table 1. Spectral data of compounds 1-3
1 (ETD) 2 3
Retention time
(HPLC-UV) 41.3 min 24.5 min 20.2 min
HR ESI-MS
(m/z)
288.2082 [M+H]+, 270.1903, 228.1623,
172.1372, 144.1033
304.1471 [M+H]+, 286.1611, 244.1440,
188.1179
320.2069 [M+H]+, 302.2107, 260.2204,
204.1767
IR (CH2Cl2)
ν (cm-1) 3430, 1721, 1077 3445, 3193, 2978, 1710, 1447 3380, 2952, 1720, 1698, 1645, 1452
UV (H2O:CH3CN
9 :1 v/v) l (nm) 225 (log ε 4.6), 272 (log ε 3.9) 255 (log ε 3.6), 225 (log ε 3.4) 286 (log ε 1.2), 340 (log ε 3.6)
NMRa/
Position dH
b dC dHb dC dHb dC
NH 4.62 (s) 7.98 (s)
2 136.7 (q)c 60.8 (q)c 172.0 (q)c
3 116.5 (q) 181.2 (q) 204.6 (q)
4 6.90 (d, 6.5) 120.2(t) 7.08 (d, 7.6) 124.0 (t) 7.49 (d, 7.7) 124.7 (t)
5 6.93 (t, 7.0) 121.2 (t) 6.98 (t, 7.5) 124.1 (t) 7.39 (t, 7.6) 128.7 (t)
6 7.24 (d, 7.6) 121.2 (t) 7.12 (d, 7.4) 127.7 (t) 7.25 (d, 7.4) 132.1 (t)
7 127.8 (q) 133.7 (q) 142.8 (q)
8 136.2 (q) 140.3 (q) 138.9 (q)
9 127.9 (q) 129.4 (q) 133.5 (q)
10 2.86 (br q, 7.6) 25.1 (s) 2.62 (dq, 7.5, 1.0) 25.4 (s) 2.77 (dq, 7.5, 1.0) 30.5 (s)
11 1.30 (t, 7.6) 14.8 (p) 1.19 (t, 7.6) 15.4 (p) 1.26 (t, 7.5) 14.2 (p)
1ʹ 77.0 (q) 89.9 (q) 80.7 (q)
3ʹ 4.09 – 3.96 (m) 61.9 (s) 4.31 (td, 9.7, 4.1),
4.17 (dd, 16.4, 8.6)
65.9 (s) 4.45 (t, 12.0),
4.16 (ddd,13.5, 4.7, 2.1)
63.7 (s)
4ʹ 2.83 – 2.63 (m) 32.2 (s) 2.78 – 2.69 (m),
2.14 (m)
39.7 (s) 3.17 (m),
2.47 (dd, 14.7, 3.4)
42.9 (s)
5ʹ 3.00 (d, 14.3),
2.87 (d, 14.3)
44.0 (s) 3.01 (d, 14.3),
2.80 (d, 14.3)
38.0 (s) 3.18 (d, 14.6),
2.86 (d, 14.6)
35.9 (s)
6ʹ 174.6 (q) 175.0 (q) 177.5 (q)
7ʹ 2.11 (q, 7.3) 23.2 (s) 1.93 (m),  1.50 (m) 28.7 (s) 2.11 (dq, 14.4, 7.3) 1.96 (dq, 23.6 (s)
12.7, 6.4)
8ʹ 0.74 (t, 7.3) 8.4 (p) 0.57 (t, 7.5) 9.0 (p) 1.13 (t, 7.5) 7.9 (p)
a Compounds 1 and 2 in CD3OD, compound 3 in CDCl3.
b 1H chemical shift values (d ppm from SiMe4) followed by multiplicity and then the coupling constants (J in Hz).
c Letters, p, s, t and q, in parentheses indicate, respectively, the primary, secondary, tertiary and quaternary carbons, assigned by HSQC and
HMBC experiments.
Table 2. Ecotoxicity results in mg/L, expressed as L(E)C50 values with confidence limits
(95%), of etodolac (1), its photostable derivative 2 and its irradiation mixture. Acute toxicity
was assessed after 24h of exposure while chronic toxicity after 48h in B. calyciflorus and 72h
in P. subcapitata.
N.E.: No Effect
C. dubia
LC50 (24h)
B. calyciflorus
LC50 (24h)
B. calyciflorus
EC50 (48 h)
P. subcapitata
EC50 (72 h)
1 N.E.up to 25
N.E.
up to 25
15.44
(5.27- 45.71)
N.E.
up to 10
2 N.E.up to 25
N.E.
up to 25
33%
effect at 25
N.E.
up to 10
Irradiation mixture N.E.up to 25
N.E.
up to 25
N.E.
up to 25
N.E.
up to 10
Table 3. Mutagenicity results expressed as Mutagenic Ratio (MR) of etodolac (1), its photostable
derivative 2 and its irradiation mixture. The salmonella mutagenicity assay was performed on S.
typhimurium TA98 and TA100 strains. In bold the MRs higher than 2.
±SD = Standard Deviation obtained from three independent experiments.
1 MR (Mutagenic Ratio): number of revertants/plate compared to the negative control
AMES TEST
TA98 TA100
Compounds Concentration(μg/mL)
Mean
revertants/plate
(± SD)
1MR Concentration(μg/mL)
Mean
revertants/plate
(± SD)
1MR
Negative Control - 50.5 ± 7.2 - - 189.7 ± 52.6 -
2- Nitrofluoren 2.5 133.6 ± 13.6 2.6 - - -
5.0 170.0 ± 25.7 3.4
10 351.3 ± 131.4 6.9
Sodium Azide - - - 5 361.0 ± 127.0 1.9
10 618.0 ± 176.7 3.2
20 862.3 ± 291.0 4.5
1
1.56 50.3 ± 10.0 1.0 1.56 194.0 ± 51.2 1.02
3.125 52.0 ± 8.0 1.03 3.125 232.0 ± 50.0 1.2
6.25 64.7 ± 1.5 1.3 6.25 198.0 ± 30.2 1.04
12.5 59.0 ± 9.5 1.2 12.5 194.6 ± 69.2 1.02
25 47.7 ± 15.3 0.9 25 272.0 ± 39.4 1.4
2
1.56 98.0 ± 25.9 1.9 1.56 189.0 ± 70.5 1.0
3.125 143.2 ± 51.3 1.8 3.125 297.3 ± 96.5 1.6
6.25 228.5 ± 120.0 4.5 6.25 349.7 ± 89.1 2.1
12.5 552.3 ± 135.3 10.9 12.5 610.0 ± 181.5 3.2
25 874.5 ± 203.3 17.3 25 1065.7 ± 214.7 5.6
Irradiation mixture
1.56 65.3 ± 8.9 1.3 1.56 218.3 ± 53.9 1.2
3.125 66.7 ± 15.7 1.3 3.125 247.3 ± 35.8 1.3
6.25 80.2 ± 19.7 1.6 6.25 229.3 ± 33.1 1.2
12.5 117.1 ± 24.1 2.3 12.5 378.7 ± 58.3 1.9
25 213.9 ± 60.9 4.2 25 287.0 ± 33.0 1.5
Table 4. Genotoxicity results expressed as Induction Ratio (IR) of etodolac (1), its photostable
derivative 2 and its irradiation mixture. UMU-test was performed on the S. typhimurium
TA1535/pSK1002 strain. In bold IRs higher than 1.5.
±SD = Standard Deviation obtained from three independent experiments.
1 IR (Induction Ratio):
UMU TEST
- S9 +S9
Compounds Concentration(μg/mL)
1IR Concentration(μg/mL)
1IR
Negative Control - 1.0 1.0
4-nitroquinoline N-oxide 0.05 3.71 ± 1.0
2-aminoanthracene 2.0 4.71 ± 0.68
1
1.56 0.45 ± 0.21 1.56 0.51 ± 0.12
3.125 0.72 ± 0.32 3.125 0.59 ± 0.11
6.25 0.66 ± 0.21 6.25 0.50 ± 0.09
12.5 0.66 ± 0.22 12.5 0.53 ± 0.11
25 0.71 ± 0.32 25 0.56 ± 0.12
2
1.56 1.08 ± 0.41 1.56 0.44 ± 0.21
3.125 1.51 ± 0.32 3.125 0.58 ± 0.19
6.25 1.92 ± 0.29 6.25 0.68 ± 0.20
12.5 1.93 ± 0.39 12.5 0.78 ± 0.21
25 1.96 ± 0.27 25 0.62 ± 0.15
Irradiation mixture
1.56 0.96 ± 0.11 1.56 0.45 ± 0.18
3.125 0.84 ± 0.31 3.125 0.79 ± 0.12
6.25 0.88 ± 0.32 6.25 0.87 ± 0.19
12.5 0.88 ± 0.33 12.5 0.98 ± 0.17
25 1.38 ± 0.72 25 1.20 ± 0.32
